Cefazolin
Loading drug information...
Failed to Load Drug Information
Please check your internet connection and try again.
Last updated: June 2025
For educational purposes only
Clinical Reference
# Cefazolin
## Overview
- **Classification**: First-generation Cephalosporin antibiotic
- **Mechanism**: Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to bacterial cell lysis.
## Primary Indications
1. **Surgical Prophylaxis**: Prevention of surgical site infections.
2. **Skin and Soft Tissue Infections**: Treatment of mild to moderate infections (e.g., cellulitis, erysipelas).
3. **Bone and Joint Infections**: Treatment of osteomyelitis and septic arthritis.
4. **Urinary Tract Infections**: Treatment of acute uncomplicated UTIs.
5. **Endocarditis Prophylaxis**: For certain dental or surgical procedures in high-risk patients.
## Adult Dosing
### Standard Dosing
**Surgical Prophylaxis**
- **Dose**: **1-2 g** IV
- **Frequency**: Administer **30-60 minutes prior to incision**.
- **Route**: Intravenous (IV)
- **Duration**: May repeat dose every **2-4 hours** intraoperatively for prolonged procedures.
- **Special Considerations**: For patients >120 kg, consider **3 g** IV.
**Mild to Moderate Infections (e.g., uncomplicated cellulitis, UTI)**
- **Dose**: **250 mg - 1 g** IV or IM
- **Frequency**: Every **6 to 8 hours**
- **Route**: Intravenous (IV), Intramuscular (IM)
- **Maximum Dose**: Typically **6 g/day**
**Severe Infections (e.g., endocarditis, osteomyelitis, septicemia)**
- **Dose**: **1 g - 2 g** IV
- **Frequency**: Every **6 to 8 hours**
- **Route**: Intravenous (IV)
- **Maximum Dose**: Up to **12 g/day** (in life-threatening situations)
### Dose Adjustments
- **Renal Impairment**: Adjust frequency based on Creatinine Clearance (CrCl).
- CrCl **50-20 mL/min**: Administer standard dose every **8 hours**.
- CrCl **19-10 mL/min**: Administer standard dose every **12 hours**.
- CrCl **<10 mL/min**: Administer standard dose every **18-24 hours**.
- **Hemodialysis**: Administer standard dose post-dialysis; supplemental doses may be needed.
- **Hepatic Impairment**: No specific dose adjustment generally needed.
- **Elderly Patients**: Adjust based on renal function (CrCl) due to age-related decline.
## Pediatric Dosing
### Neonates (0-28 days)
- **Mild to Moderate Infections**
- **< 7 days old (<2000 g)**: **25 mg/kg/dose** IV
- **Frequency**: Every **12 hours**
- **< 7 days old (>2000 g)**: **25 mg/kg/dose** IV
- **Frequency**: Every **8 hours**
- **7-28 days old (<2000 g)**: **25 mg/kg/dose** IV
- **Frequency**: Every **8 hours**
- **7-28 days old (>2000 g)**: **25 mg/kg/dose** IV
- **Frequency**: Every **6 hours**
- **Maximum**: **100 mg/kg/day** for treatment, or up to **50 mg/kg/day** for prophylaxis.
- **Special Notes**: Use cautiously; immature renal function increases risk of accumulation.
### Infants (1-12 months)
- **Mild to Moderate Infections**: **25-50 mg/kg/day** IV or IM
- **Frequency**: Divided every **8 hours**
- **Severe Infections**: **100 mg/kg/day** IV or IM
- **Frequency**: Divided every **6-8 hours**
- **Maximum**: **6 g/day**
### Children (1-12 years)
- **Mild to Moderate Infections**: **25-50 mg/kg/day** IV or IM
- **Frequency**: Divided every **8 hours**
- **Severe Infections**: **100 mg/kg/day** IV or IM
- **Frequency**: Divided every **6-8 hours**
- **Maximum**: **6 g/day** (or adult maximum dose, whichever is less)
### Adolescents (13-18 years)
- **Dose**: Generally follows **adult dosing** guidelines.
- **Maximum**: Up to **12 g/day** (for severe infections), otherwise **6 g/day**.
## Safety Information
### Contraindications
- **Absolute**: Known serious **hypersensitivity** to cefazolin or any other cephalosporin antibiotics.
- **Absolute**: History of immediate and severe **hypersensitivity reaction to penicillin** (e.g., anaphylaxis, Stevens-Johnson syndrome).
- **Relative**: History of non-severe penicillin allergy (monitor closely for cross-reactivity).
### Common Adverse Effects
- **Common (1-10%)**:
- **Gastrointestinal**: Nausea, vomiting, diarrhea.
- **Injection site**: Pain, tenderness, phlebitis (IV), induration (IM).
- **Hypersensitivity**: Rash, pruritus.
- **Hematologic**: Eosinophilia, leukopenia.
- **Serious but Rare**:
- **Anaphylaxis**: Severe allergic reaction, angioedema.
- **Clostridioides difficile-associated diarrhea (CDAD)**: Pseudomembranous colitis.
- **Seizures**: Especially with high doses in renal impairment.
- **Nephrotoxicity**: Acute interstitial nephritis.
- **Hematologic**: Neutropenia, thrombocytopenia, hemolytic anemia.
### Key Drug Interactions
- **Warfarin**: May **increase INR** and bleeding risk; monitor INR closely.
- **Nephrotoxic Agents (e.g., aminoglycosides, loop diuretics)**: Concomitant use may **increase risk of renal toxicity**; monitor renal function.
- **Probenecid**: **Decreases renal clearance** of cefazolin, leading to higher and more prolonged serum concentrations.
## Monitoring & Follow-up
- **Before Treatment**:
- Obtain **allergy history** (especially to beta-lactams).
- Assess **renal function** (CrCl) to guide dosing.
- **During Treatment**:
- Monitor for **signs of allergic reaction** (e.g., rash, dyspnea).
- Monitor for **gastrointestinal side effects** (e.g., diarrhea, abdominal pain).
- Monitor **renal function** in patients with pre-existing impairment or on concurrent nephrotoxic drugs.
- Monitor for **superinfection** (e.g., oral candidiasis, vaginal yeast infection, CDAD).
- Assess **clinical response** to therapy.
- **Clinical Signs**: Watch for persistent fever, new rash, significant diarrhea, decreased urine output, or neurological changes.
## Clinical Pearls
- 💡 **Gram-positive Coverage**: Excellent activity against many **Gram-positive cocci**, including methicillin-susceptible *Staphylococcus aureus* (MSSA) and streptococci.
- 💡 **Surgical Prophylaxis Staple**: It's a first-line choice for preventing infections in many surgical procedures due to its spectrum and favorable safety profile.
- 💡 **Administration**: Administer **IV or IM only**; no oral formulation. Ensure proper IV dilution and infusion rate.
- 💡 **Penicillin Allergy**: Cross-reactivity with penicillin is generally **low (about 1%)** for first-generation cephalosporins, but caution is warranted with severe penicillin allergy.
- 💡 **Renal Dosing**: Always **dose adjust in renal impairment** to prevent accumulation and potential adverse effects like seizures.
> **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.